The University of Chicago Header Logo

Connection

Wendy Stock to Central Nervous System Diseases

Back to Details
This is a "connection" page, showing publications Wendy Stock has written about Central Nervous System Diseases.
Wendy Stock
Connection Strength
0.013
Central Nervous System Diseases
  1. Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013. Leuk Lymphoma. 2003 Jan; 44(1):39-48.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.